|
|
Volumn 2, Issue 3, 1997, Pages 234-237
|
|
MADIT does not provide the basis for developing therapeutic strategy for patients with severely depressed ventricular ejection fraction with nonsustained ventricular tachycardia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
SOTALOL;
CLINICAL TRIAL;
DEFIBRILLATOR;
FUNCTIONAL ASSESSMENT;
HEART ARRHYTHMIA;
HEART INFARCTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
REVIEW;
SUDDEN DEATH;
|
|
EID: 0031406099
PISSN: 10742484
EISSN: None
Source Type: Journal
DOI: 10.1177/107424849700200311 Document Type: Review |
|
Times cited : (1)
|
|
References (12)
|
